Home > PS Ratio > ORCHID PHARMA

ORCHID PHARMA
PS (Price/Sales) Ratio

The Current P/S Ratio of ORCHID PHARMA is 6.52.

Share Price ₹1,045.2Mar 28,2024
Market Cap ₹5,299.2 Cr
Sales-TTM₹812.2 CrTTM-Consolidated Results
Price/Sales6.52xCalculated as Market Cap/Sales
Explore Stock Analytics
COMMUNITY POLL
for ORCHID PHARMA
Please provide your vote to see the results
ORCHID PHARMA is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks

Definition & Calculation of PS (Price/Sales) ratio of ORCHID PHARMA

Price-to-Sales ratio, P/S Multiple, or P/S Ratio is an important valuation multiple that is defined as:

P/S = Market Capitalization / Sales

or, using per-share numbers:

P/S = Stock Price / Sales Per Share

Applying the above formula, P/S ratio of ORCHID PHARMA is calculated as :

Current Market Cap [ ₹5,299.2 Cr] as on Mar 28,2024

(/) Sales [ ₹812.2 Cr] based on TTM-Consolidated Results

(=) P/S Ratio [ 6.52x ]

P/S Ratio indicates 'the multiple of sales' investors are willing to pay to own one share of the company.

Thus, for ORCHID PHARMA , the investors are currently willing to pay '6.52 times sales' to own 1 share of the company.

PS Multiples are one of the most widely used valuation multiple in the industry.

P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.

You may also explore Price to Earnings ratio or Price to Book ratio of ORCHID PHARMA !

The chart below summarizes the trend in P/S Ratio of ORCHID PHARMA over the last five years.

Historical PS (Price/Sales) ratio chart of ORCHID PHARMA


PS Ratio Performance Analysis for ORCHID PHARMA

- ORCHID PHARMA 's latest p/e ratio is 6.52x.

- ORCHID PHARMA 's p/e ratio for fiscal years ending Mar2023 to Mar2019 averaged 5.37x.

- ORCHID PHARMA 's operated at median p/e ratio of 2.07x from fiscal years ending March 2018 to 2022.

- Looking back at the last 5 fiscal years, ORCHID PHARMA 's p/e ratio peaked in Mar2021 at 22.36x.

- ORCHID PHARMA 's p/e ratio hit its five-year low in Mar2020 of 0x.


How does ORCHID PHARMA 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?

Peer Comparison (Pharmaceuticals & Drugs Industry)Sales (Cr)PS RatioMarket Cap (Cr)
ORCHID PHARMA 812.26.525,299.2
SUN PHARMACEUTICAL INDUSTRIES LTD47,444.68.20388,812.0
CIPLA LTD25,350.24.76120,673.0
DR REDDYS LABORATORIES LTD27,212.53.77102,679.0
ZYDUS LIFESCIENCES LTD19,024.25.32101,152.0
DIVIS LABORATORIES LTD7,492.812.1891,234.9
MANKIND PHARMA LTD9,946.39.2592,029.2
TORRENT PHARMACEUTICALS LTD10,474.08.4188,034.7
LUPIN LTD19,480.13.7873,722.0
AUROBINDO PHARMA LTD27,894.72.2963,835.1
ABBOTT INDIA LTD5,753.49.9557,258.4

Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs ORCHID PHARMA 's P/S Ratio

Top 10 Industry PeersPS Ratio
Min industry PS 2.29x
Max industry PS 12.18x
Median industry PS 6.52x
Average industry PS 6.77x



You may also like the below Video Courses